INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Corporate insider
LO

Loeillot Olivier

Director, Chief Executive OfficerCIK 0001995525

EDGAR filingsOpen in network
Disclosed transactions6
Buys / sells0 / 2
Max Insider Score18
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Option exercise · 10b5-1 plan
M$1.30M
8,404 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    REPLIGEN CORPDirector, Chief Executive Officer · Sep 25, 2026
18
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Open-market sale · 10b5-1 plan
SELL
$1.60M
8,404 sh
Sep 24, 2026
Sep 25, 2026
traded Sep 24, 2026
+1d
SEC FORM 4

Evidence

9
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Option exercise · 10b5-1 plan
M$706K
4,542 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

15
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Open-market sale · 10b5-1 plan
SELL$863K
4,542 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

11
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Option exercise · 10b5-1 plan
M—
4,542 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence

11
LO
Loeillot OlivierDirector, Chief Executive Officer
RGENREPLIGEN CORP
Option exercise · 10b5-1 plan
M—
8,404 sh
Sep 24, 2026Sep 25, 2026
traded Sep 24, 2026
+1dSEC FORM 4

Evidence